LP-184 is specifically activated in tumor cells to an active compound by the oxidoreductase enzyme prostaglandin reductase 1 (PTGR1), that is frequently overexpressed in multiple solid tumor types (22, 23). This evidence concerns the gene PTGR1 and neoplasm.